AMRI licenses Teewinot's cannabinoid analytical standard production tech

By Gareth Macdonald contact

- Last updated on GMT

iStock/Thom_Morris
iStock/Thom_Morris

Related tags: Research, Technology

AMRI has licensed technology needed to make an analytical standard drug firms working with cannabinoids can use for research and quality control.

The technology used to make the CBCA analytical standard was developed by Teewinot Life Sciences.

Teewinot CEO Jeffrey Korentur told us “researchers will be able to use the standard validate and confirm that the compound they are using either is, or is not, CBCA. Standards may have other uses in research and development including preliminary efficacy studies​.”

He added that: “AMRI is licensed to use our technology to manufacture and sell the CBCA analytical standard​.”

Teewinot has a suite of biosynthetic technologies it uses to make cannabinoid-based compounds in micro-organisms.

The idea is that the approach is faster and more consistent than plant-based production.

Scale-up

The agreement with AMRI is seperate to the deal Teewinot has with the US contractor to scale up the cannabinoid production process.

Korentur told us: “Our scale up is in progress now, and we anticipate being able to produce kilogram quantities of GMP manufactured cannabinoids by Q1 2017​.”

Tech license

News of the deal comes a week after Florida-based Teewinot licensed rights to its cannabinoid active pharmaceutical ingredient (API) manufacturing technology to Nemus Biosciences.

That agreement was signed days after Teewinot’s Ireland-based subsidiary, Full Spectrum Laboratories, was granted a US patent​ for the technology. 

Related news

Show more

Related products

show more

How to measure powder and granule flow properties

How to measure powder and granule flow properties

Stable Micro Systems | 01-Apr-2019 | Technical / White Paper

Being able to predict, optimise and control powder flow is of prime importance to manufacturers in ensuring high quality standards. Download this free...

The battle of performance in pharma production

The battle of performance in pharma production

Telstar Life Science Solutions | 26-Mar-2019 | Case Study

Telstar case study. Discover how a versatile freeze-dryer automatic loading & unloading systemDiscover how a versatile freeze-dryer automatic loading...

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 17-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...

Related suppliers